Is Taysha Gene Therapies, Inc. (TSHA) a Buy, Sell, or Hold?
Taysha Gene Therapies, Inc.
NASDAQ:TSHA
$5.7 USD
$0.32 (5.95%)
- Volume
- 4.26M
- Average Volume
- 3.11M
- Market Capitalization
- $1.43B
- P/E Ratio
- -14.89
- Dividend Yield
- 0.00%
- Price Target
- $14.50
- Year High
- $7.30
- Year Low
- $2.34
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $14.04
TSHA vs. The Competition
| Properties | TSHA | ANAB | ATAI | BBOT |
|---|---|---|---|---|
| Market Cap | $1.43B | $2.7B | $2.09B | $706.54M |
| Shares Outstanding | $250.23M | $43.12M | $368.17M | $80.11M |
| P/E Ratio | -14.89 | -73.54 | -1.89 | -1.54 |
| EPS | -0.35 | -0.93 | -2.93 | -4.95 |
| Day Low | 5.31 | 62.34 | 4.97 | 8.39 |
| Day high | 5.855 | 70 | 5.77 | 9.05 |
| Year Low | 2.34 | 11.404 | 2.58 | 7 |
| Year High | 7.3 | 72.36 | 6.75 | 14.87 |
| Average Price 50 | 6.1482 | 60.7778 | 4.3839 | 8.137 |
| Average Price 200 | 5.14015 | 39.77828 | 4.30085 | 10.36725 |
| Volume | 4.26M | 623.07K | 11.88M | 424.38K |
| Average Volume | - | - | - | - |